Gene · 1286
Papers1,462
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,462
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic significance and multivariate modeling of COL4A family genes and HMGA2 in glioma. | Front Pharmacol | 2025 | 40351420 | PubTator, text mining | PubMed |
| [New Genetic Variants Involved in the Pathogenesis of Autosomal Dominant Alport Syndrome: A Familial Case Report]. | G Ital Nefrol | 2025 | 40332975 | PubTator, text mining | PubMed |
| Mechanism of etoposide resistance in small cell lung cancer and the potential therapeutic options. | Med Oncol | 2025 | 40257680 | PubTator, text mining | PubMed |
| Phenotype-genotype correlations in patients with Alport syndrome from the Polish population. | J Nephrol | 2025 | 40237890 | PubTator, text mining | PubMed |
| Small Extracellular Vesicles From Hypoxia-Neuron Maintain Blood-Brain Barrier Integrity. | Stroke | 2025 | 40171669 | PubTator, text mining | PubMed |
| Whole exome sequencing shows novel COL4A3 and COL4A4 variants as causes of Alport syndrome in Rio Grande do Norte, Brazil. | BMC Genomics | 2025 | 40169949 | PubTator, text mining | PubMed |
| C-Terminal Hsp90 Inhibitors Overcome MEK and BRAF Inhibitor Resistance in Melanoma. | J Cell Mol Med | 2025 | 40135438 | PubTator, text mining | PubMed |
| Pathogenic variants in the Alport genes are prevalent in the Singapore multiethnic population with highest frequency in the Chinese. | Sci Rep | 2025 | 40044766 | PubTator, text mining | PubMed |
| Molecular Review of Suspected Alport Syndrome Patients-A Single-Centre Experience. | Genes (Basel) | 2025 | 40004525 | PubTator, text mining | PubMed |
| COL4A5 Intronic Variants at Third to Fifth Nucleotides Cause Alport Syndrome. | Kidney Int Rep | 2025 | 39990911 | PubTator, text mining | PubMed |
| SPP1hi macrophages, NKG7 T cells, CCL5hi fibroblasts, and IgM plasma cells are dominant features of necrobiosis. | JCI Insight | 2025 | 39989459 | PubTator, text mining | PubMed |
| Tracing glass production in urban centers along the Silk Roads in the early Islamic period. | iScience | 2025 | 39981515 | PubTator, text mining | PubMed |
| Effects of a Novel COL4A3 Homozygous/Heterozygous Splicing Mutation on the Mild Phenotype in a Family With Autosomal Recessive Alport Syndrome and a Literature Review. | Mol Genet Genomic Med | 2025 | 39924725 | PubTator, text mining | PubMed |
| Case of maternal uniparental isodisomy with autosomal recessive Alport syndrome combined with congenital myasthenia and Oguchi disease. | CEN Case Rep | 2025 | 39913008 | PubTator, text mining | PubMed |
| A Novel Loss-of-Function Variant in COL4A3 in a Consanguineous Moroccan Family Displaying the Alport Syndrome with Variable Clinical Expression. | Mol Syndromol | 2025 | 39911173 | PubTator, text mining | PubMed |
| A 15-year experience highlighting the spectrum of Alport kidney disease in the pediatric population and novel genetic variants in COL4A3-5. | Pediatr Nephrol | 2025 | 39907758 | PubTator, text mining | PubMed |
| Exon location of glycine substitutions impacts kidney survival in autosomal dominant Alport syndrome. | Nephrol Dial Transplant | 2025 | 39810285 | PubTator, text mining | PubMed |
| Challenging the narrative of Alport syndrome spectrum: no link with cystic phenotype. | Nephrol Dial Transplant | 2025 | 39694697 | PubTator, text mining | PubMed |
| Synergistic toxicity of compound heterozygous mutations in the COL4A3 gene causes end-stage renal disease in A large family of Alport syndrome. | Gene | 2025 | 39615805 | PubTator, text mining | PubMed |
| Genetic testing in a national cohort of adults with chronic kidney disease of unknown origin. | Nephrol Dial Transplant | 2025 | 39562282 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1286/papers?page=6